Aclipse Therapeutics Announces $1.475 Million Award from the US Department of Defense - Business Wire

Aclipse Therapeutics Announces $1.475M Award from the U.S. Department of Defense to Support Aclipse's Continued Development of M102 in ALS

RADNOR, Pa.--(BUSINESS WIRE)--Aclipse Therapeutics and its subsidiary Aclipse One Inc (Aclipse or the Company), an innovative biopharmaceutical company, today announced that the Company has received … [+7079 chars]

full article...